APA (7th ed.) Citation

Leonhardt, S., Baumann, S., Jürgensen, C., Hüter, L., & Leonhardt, J. (2023). Role of intravenous ketamine in the pathogenesis of secondary sclerosing cholangitis in critically ill patients: Perpetrator or innocent bystander? Answers provided by forensic toxicology. Intensive care medicine, 49(12), 1549-1551. https://doi.org/10.1007/s00134-023-07257-8

Chicago Style (17th ed.) Citation

Leonhardt, Silke, Sven Baumann, Christian Jürgensen, Lars Hüter, and Julia Leonhardt. "Role of Intravenous Ketamine in the Pathogenesis of Secondary Sclerosing Cholangitis in Critically Ill Patients: Perpetrator or Innocent Bystander? Answers Provided by Forensic Toxicology." Intensive Care Medicine 49, no. 12 (2023): 1549-1551. https://doi.org/10.1007/s00134-023-07257-8.

MLA (9th ed.) Citation

Leonhardt, Silke, et al. "Role of Intravenous Ketamine in the Pathogenesis of Secondary Sclerosing Cholangitis in Critically Ill Patients: Perpetrator or Innocent Bystander? Answers Provided by Forensic Toxicology." Intensive Care Medicine, vol. 49, no. 12, 2023, pp. 1549-1551, https://doi.org/10.1007/s00134-023-07257-8.